Back to search
Pharmacogenomic Drug Interaction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pharmacogenomic Drug Interaction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pharmacogenomic Drug Interaction trials you may qualify forIt is known that individuals respond differently to the same medicine with some people benefitting, some experiencing no effect and others suffering side-effect…
A five-year prospective observational cohort study. The study is focused on observing the relation between static germline variants and therapeutic response in…
The goal of this project is to determine whether pharmacogenomic testing (using participants' DNA) can help optimize medication prescribing and reduce side effe…
The purpose of this study is to determine whether the implementation of pre-emptive pharmacogenomic (PGx) testing of a panel of clinically relevant PGx markers,…
The goal of this clinical trial is to evaluate how differences in specific parts of our DNA can influence how individual bodies break down the hormones containe…
This study looks at how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy. The study aims to understand how trihexyphenidyl is br…
The goal of this prospective, randomized clinical trial is to learn whether pharmacogenomic (PGx)-guided comprehensive medication management delivered by pharma…
The goal of this research study is to reduce adverse effects of anti-cancer medications known as kinase inhibitors, while preserving their therapeutic benefits.…